BioSpace News Archive

Deals

Ajinomoto Targets Gene Therapy Space with $620M Forge Acquisition

The Japanese biotechnology and food company has bought into the gene therapy space with its $620 million acquisition of Ohio-based CDMO and clinical-stage biotech Forge Biologics.

November 14, 2023
·
2 min read
·
Tristan Manalac
Drug Development

AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop

When given with chemoradiotherapy, Imfinzi in a late-stage non-small cell lung cancer study did not lead to significant improvements in progression-free survival versus chemoradiotherapy alone.

November 14, 2023
·
2 min read
·
Tristan Manalac
Business

Israeli Biopharma Execs Vow Resilience, Anticipate Long-Term Fallout from Gaza War

Executives from Israel-based companies express concern about future investment and other operational impacts, as the war rages on in Gaza with tragic loss of life amid political and economic uncertainties.

November 14, 2023
·
5 min read
·
Heather McKenzie
Drug Development

Ipsen, Genfit Build Case for Rare Liver Disease Drug with Phase III Data

In a late-stage trial, treatment with Ipsen and Genfit’s elafibranor led to high rates of biochemical response and the normalization of alkaline phosphatase levels compared with placebo.

November 14, 2023
·
2 min read
·
Tristan Manalac
Business

Jazz Inks $770M Deal with GSK Spinout Autifony, Nabs Two Neuro Assets

Under the potential $770.5 million deal announced Tuesday, Autifony Therapeutics is licensing to Jazz Pharmaceuticals two ion channel targets associated with neurological disorders.

November 14, 2023
·
2 min read
·
Tyler Patchen
IN PARTNERSHIP WITH ANIMA BIOTECH

Webinar: mRNA Is Never Naked, Exploring RBP Target Space & Therapeutic Opportunities

Watch this webinar to gain insights from expert speakers, Dr. Iris Alroy and Dr. Kristopher Brannan, who have made significant advancements in the field of RBPs.

November 14, 2023
·
2 min read
Policy

Opinion: How Biotechs Can Prepare for the Next Decade by Rethinking Conventional Business Models

In today’s challenging environment, here are some creative ways biotechs have found to survive and thrive.

November 14, 2023
·
5 min read
·
Cem Zorlular and Mert Zorlular
FDA

Zepbound vs Wegovy: A Two-Horse Race

In this episode BioSpace’s Greg Slabodkin, Tyler Patchen and Lori Ellis discuss Zepbound, Wegovy, the weight loss race and the future of this drug class.

November 14, 2023
·
1 min read
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round

Nouscom announced the completion of its oversubscribed Series C equity financing raising €67.5 million from a syndicate of renowned international healthcare investors.

November 14, 2023
·
8 min read
Business

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

BiomX Inc. reported financial results and provided a business update for the third quarter ended September 30, 2023.

November 14, 2023
·
11 min read